Cargando…

Urinary adiponectin and progression of diabetic nephropathy in type 1 diabetes

The complex role of adiponectin in diabetic nephropathy. [Image: see text]

Detalles Bibliográficos
Autores principales:	Ha, Kyoung Hwa, Kim, Dae Jung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931195/ https://www.ncbi.nlm.nih.gov/pubmed/27182041 http://dx.doi.org/10.1111/jdi.12427

Ejemplares similares

Adiponectin for the treatment of diabetic nephropathy
por: Lee, Jun Young, et al.
Publicado: (2019)

Does Losartan Prevent Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes?
por: Nicholas, Susanne B., et al.
Publicado: (2013)

Epigenetic regulation of core genes linking to diabetic nephropathy progression: Lesson from FinnDiane type 1 diabetes study
por: Makino, Hirofumi, et al.
Publicado: (2023)

Urinary Liver-Type Fatty Acid–Binding Protein and Progression of Diabetic Nephropathy in Type 1 Diabetes
por: Panduru, Nicolae M., et al.
Publicado: (2013)

Epidermal growth factor receptor signaling and the progression of diabetic nephropathy
por: Koya, Daisuke
Publicado: (2015)

Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes
por: Mutter, Stefan, et al.
Publicado: (2021)

Urinary adiponectin as a new diagnostic index for chronic kidney disease due to diabetic nephropathy
por: Yamakado, Shinnosuke, et al.
Publicado: (2019)

Adiponectin improves diabetic nephropathy by inhibiting necrotic apoptosis
por: Yi, Wei, et al.
Publicado: (2018)

Adiponectin retards the progression of diabetic nephropathy in db/db mice by counteracting angiotensin II
por: Guo, Xiaohua, et al.
Publicado: (2014)

Adiponectin Can Be an Early Predictable Marker for Type 2 Diabetes Mellitus and Nephropathy
por: Ganesh, Veluri, et al.
Publicado: (2022)

The Challenging Search for Diabetic Nephropathy Genes
por: Bowden, Donald W., et al.
Publicado: (2012)

Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes
por: Argyropoulos, Christos, et al.
Publicado: (2013)

Urinary Cystatin C and Tubular Proteinuria Predict Progression of Diabetic Nephropathy
por: Kim, Sang Soo, et al.
Publicado: (2013)

Age at Diagnosis and the Risk of Diabetic Nephropathy in Young Patients with Type 1 Diabetes Mellitus
por: Baek, Jong Ha, et al.
Publicado: (2021)

Urinary biomarkers for early diabetic nephropathy in type 2 diabetic patients
por: Fiseha, Temesgen
Publicado: (2015)

Urinary TNF-α and NGAL are correlated with the progression of nephropathy in patients with type 2 diabetes
por: WU, JIAN, et al.
Publicado: (2013)

3-Hydroxybutyrate Ameliorates the Progression of Diabetic Nephropathy
por: Jung, Jeeyoun, et al.
Publicado: (2022)

Diabetic Nephropathy: Emerging Biomarkers for Risk Assessment
por: Badal, Shawn S., et al.
Publicado: (2015)

Losartan and diabetic nephropathy: commentaries on the RENAAL study
por: Fisman, Enrique Z, et al.
Publicado: (2002)

Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients
por: Nielsen, Stine Elkjaer, et al.
Publicado: (2010)

Lessons from a cardiovascular outcome trial with liraglutide in type 2 diabetes
por: Kim, Hae Jin, et al.
Publicado: (2017)

Vitamin D in diabetic nephropathy
por: Prabhu, RA, et al.
Publicado: (2018)

Correction: Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes
por: Argyropoulos, Christos, et al.
Publicado: (2013)

Discordance in risk factors for the progression of diabetic retinopathy and diabetic nephropathy in patients with type 2 diabetes mellitus
por: Song, Ki‐Ho, et al.
Publicado: (2018)

Taurine Alleviates the Progression of Diabetic Nephropathy in Type 2 Diabetic Rat Model
por: Koh, Jang Hyun, et al.
Publicado: (2014)

Trends in the Diabetes Epidemic in Korea
por: Ha, Kyoung Hwa, et al.
Publicado: (2015)

Nrf2 Activators as Attractive Therapeutics for Diabetic Nephropathy
por: de Haan, Judy B.
Publicado: (2011)

Values and Limitations of Targeting lncRNAs in Diabetic Nephropathy
por: Long, Jianyin, et al.
Publicado: (2018)

Association of Adiponectin Gene Polymorphisms With Type 2 Diabetes in an African American Population Enriched for Nephropathy
por: Bostrom, Meredith A., et al.
Publicado: (2009)

Progressive Renal Decline: The New Paradigm of Diabetic Nephropathy in Type 1 Diabetes
por: Krolewski, Andrzej S.
Publicado: (2015)

Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial
por: Lin, Julie, et al.
Publicado: (2008)

Urinary nephrin linked nephropathy in type-2 diabetes mellitus
por: Rangaswamaiah, Hareesh, et al.
Publicado: (2022)

Urinary adiponectin and albuminuria in non-diabetic hypertensive patients: an analysis of the ESPECIAL trial
por: Han, Seung Seok, et al.
Publicado: (2015)

Mitochondrial reactive oxygen species in the pathogenesis of early diabetic nephropathy
por: Nishikawa, Takeshi, et al.
Publicado: (2015)

Bilirubin: A Potential Biomarker and Therapeutic Target for Diabetic Nephropathy
por: Hull, Travis D., et al.
Publicado: (2014)

CREDENCE: A silver lining in the dark cloud of diabetic nephropathy
por: Hanai, Ko, et al.
Publicado: (2019)

Response: Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index (Diabetes Metab J 2018;42:137-46)
por: Ha, Kyoung Hwa, et al.
Publicado: (2018)

Annexin 1 Mimetic Ac2-26 Holds Promise for the Treatment of Diabetic Nephropathy
por: Pan, Yu, et al.
Publicado: (2021)

Current status of managing diabetes mellitus in Korea
por: Ha, Kyoung Hwa, et al.
Publicado: (2016)

Association and biomarker potential of elevated serum adiponectin with nephropathy among type 1 and type 2 diabetics: A meta-analysis
por: Pabalan, Noel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ik72tbulukddstpkm8ptnm8g5g